Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Enveric Biosciences stock

Own Enveric Biosciences stock in just a few minutes.

Enveric Biosciences Inc is an information technology services business based in the US. Enveric Biosciences shares (AMRH) are listed on the NASDAQ and all prices are listed in US Dollars. Enveric Biosciences employs 397 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Enveric Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMRH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Enveric Biosciences share price

Use our graph to track the performance of AMRH stocks over time.

Enveric Biosciences shares at a glance

Information last updated 2021-04-04.
52-week range$3.61 - $9.96
50-day moving average $4.60
200-day moving average $5.42
Wall St. target price$0.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.50

Buy Enveric Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Enveric Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Enveric Biosciences financials

Revenue TTM $35.4 million
Gross profit TTM $8.2 million
Return on assets TTM -13.48%
Return on equity TTM -51.83%
Profit margin -19.34%
Book value $2.30
Market capitalisation $2.8 million

TTM: trailing 12 months

Shorting Enveric Biosciences shares

There are currently 49,909 Enveric Biosciences shares held short by investors – that's known as Enveric Biosciences's "short interest". This figure is 59.5% down from 123,187 last month.

There are a few different ways that this level of interest in shorting Enveric Biosciences shares can be evaluated.

Enveric Biosciences's "short interest ratio" (SIR)

Enveric Biosciences's "short interest ratio" (SIR) is the quantity of Enveric Biosciences shares currently shorted divided by the average quantity of Enveric Biosciences shares traded daily (recently around 1.2 million). Enveric Biosciences's SIR currently stands at 0.04. In other words for every 100,000 Enveric Biosciences shares traded daily on the market, roughly 40 shares are currently held short.

However Enveric Biosciences's short interest can also be evaluated against the total number of Enveric Biosciences shares, or, against the total number of tradable Enveric Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Enveric Biosciences's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Enveric Biosciences shares in existence, roughly 0 shares are currently held short) or 0.0044% of the tradable shares (for every 100,000 tradable Enveric Biosciences shares, roughly 4 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Enveric Biosciences.

Find out more about how you can short Enveric Biosciences stock.

Enveric Biosciences share dividends

We're not expecting Enveric Biosciences to pay a dividend over the next 12 months.

Have Enveric Biosciences's shares ever split?

Enveric Biosciences's shares were split on a 1:4 basis on 30 December 2020. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Enveric Biosciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Enveric Biosciences shares which in turn could have impacted Enveric Biosciences's share price.

Enveric Biosciences share price volatility

Over the last 12 months, Enveric Biosciences's shares have ranged in value from as little as $3.61 up to $9.96. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enveric Biosciences's is 5.7281. This would suggest that Enveric Biosciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Enveric Biosciences overview

Ameri Holdings, Inc. , through its subsidiaries, provides SAP cloud, digital, and enterprise services worldwide. The company offers cloud services, including public, private, and hybrid cloud services, as well as SAP S/4 HANA, SAP SuccessFactors, and SAP Hybris cloud migration; and cloud automation solutions. It also provides digital services, such as Simple Advance Planning and Optimization mobile solution, a mobile application that offers sales professionals with real-time collaboration capabilities and customer data on their mobile devices; SAP IBP mobile app, which enables the real-time management and analysis of sales and operations planning related data from mobile devices; and robotic process automation that leverages the capability of artificially intelligent software agents for business process automation, as well as for reporting and analysis, and deliver insights into business functions by translating large data into structured reports. In addition, the company's digital services comprise automating disparate and redundant data entry tasks by configuring software robots to integrate with existing software systems; and automating standard back office operations. Additionally, it designs, implements, and manages business intelligence and analytics solutions; generates instant financial reports and analytics of customer, product, and cost information; solutions for metadata repository, master data management, and data quality; and other enterprise services, such as consulting services for global and regional SAP implementations, as well as SAP/ information technology (IT) solution advisory and architectural, project management, IT/ enterprise resource planning (ERP) strategy, and vendor selection services. The company also offers data warehousing and other ERP services.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site